Medicare Enrolled
Dr. Jason Grotas, MD
Urology Physician · Lawrence, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Grotas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Grotas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Grotas
Dr. Jason Grotas is an urology physician in Lawrence, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Grotas performed 6,916 Medicare services across 4,458 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grotas received a total of $2,448 from 24 pharmaceutical and/or device companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grotas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 13% volume in NY
$2,448 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,916
Medicare services
Top 13% in NY for urology physician
4,458
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~346 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,129 | $104 | $175 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
846 | $8 | $15 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
824 | $2 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
641 | $73 | $126 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
436 | $50 | $120 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
398 | $10 | $50 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
360 | $133 | $400 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
337 | $94 | $120 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
292 | $0 | $12 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
266 | $11 | $120 |
| Assessment of muscle signal of pelvic nerves This procedure evaluates the electrical activity or signal of muscles innervated by the pelvic nerves. It is used to assess the functional status of these nerves and the muscles they control. |
223 | $262 | $550 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
195 | $59 | $550 |
| Injection, garamycin, gentamicin, up to 80 mg | 126 | $2 | $25 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
113 | $349 | $800 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
111 | $313 | $638 |
| Ultrasound of scrotum An imaging test that uses sound waves to create pictures of the scrotum and its contents. It helps evaluate the testicles and surrounding structures. |
94 | $91 | $120 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
84 | $139 | $250 |
| Biofeedback training for bowel or bladder control, initial 15 minutes A 15-minute session using biofeedback techniques to help patients gain control over bowel or bladder functions. The training involves monitoring physiological processes to learn how to manage muscle activity. |
64 | $74 | $200 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
60 | $755 | $2,000 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
58 | $156 | $300 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
51 | $17 | $125 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
46 | $723 | $2,000 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
41 | $43 | $120 |
| Telephone or internet consultation, 21-30 minutes A remote assessment conducted by a consulting physician via telephone or internet, including verbal discussion and a written report, lasting 21 to 30 minutes. |
39 | $36 | $150 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
33 | $104 | $152 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
23 | $226 | $413 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $118 | $200 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
12 | $55 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,448
Total received (2018-2024)
Avg $350/year across 7 years
Top 48% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
148
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,398 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$50 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$528
2023
$404
2022
$389
2021
$395
2020
$215
2019
$251
2018
$267
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$266
IRONWOOD PHARMACEUTICALS, INC
$76
Janssen Biotech, Inc.
$72
Tolmar, Inc.
$56
Astellas Pharma US Inc
$35
Bayer Healthcare Pharmaceuticals Inc.
$22
Top 3 companies account for 78.6% of 2024 payments
All-time payments by company (2018-2024) ›
Sumitomo Pharma America, Inc.
$477
Astellas Pharma US Inc
$348
Janssen Biotech, Inc.
$273
PFIZER INC.
$227
UROVANT SCIENCES INC
$197
Teleflex LLC
$97
Myovant Sciences Inc.
$94
Tolmar, Inc.
$90
Acerus Pharmaceuticals Corporation
$87
NeoTract Inc.
$86
IRONWOOD PHARMACEUTICALS, INC
$76
Ironwood Pharmaceuticals, Inc
$57
AstraZeneca Pharmaceuticals LP
$45
Boston Scientific Corporation
$44
Bayer Healthcare Pharmaceuticals Inc.
$41
Ferring Pharmaceuticals Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$32
Endo Pharmaceuticals Inc.
$29
Avadel Specialty Pharmaceuticals, LLC
$26
NxThera, Inc.
$18
Coloplast Corp
$18
TOLMAR Pharmaceuticals, Inc.
$17
Clarus Therapeutics Inc.
$17
Merck Sharp & Dohme Corporation
$15
Top 3 companies account for 44.8% of all-time payments
Associated products mentioned in payments ›
AVEED · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL - BPH · JATENZO · KEYTRUDA · LYNPARZA · Linzess · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · REZUM · Rezum · SPEEDICATH · TOVIAZ · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
594
Per 100K population
42.8
County median income
$143,408
Nearest hospital
ST JOHN'S EPISCOPAL HOSPITAL AT SOUTH SHORE
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Grotas is a clinical cardiology specialist, with above-average Medicare volume (top 13% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Grotas experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Grotas performed 1,129 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Grotas receive payments from pharmaceutical companies?
Yes. Dr. Grotas received a total of $2,448 from 24 companies across 148 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Grotas's costs compare to other urology physicians in Lawrence?
Dr. Grotas's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Grotas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lawrence
Browse urology physicians in Lawrence ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology